Xenetic Biosciences- Warrants (19/07/2024) Net Tangible Assets

The latest net tangible assets for XBIOW is $6.1M as of June 2026. That compares with $4.5M in the prior-year period — up 36.5% year over year. Investors often review this figure alongside Xenetic Biosciences- Warrants (19/07/2024)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, XBIOW's net tangible assets moved from $4.5M to $6.1M — a 36.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Xenetic Biosciences- Warrants (19/07/2024)'s operating scale or balance-sheet position.

A net tangible assets figure of $6.1M for XBIOW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting XBIOW's net tangible assets ($6.1M), review year-over-year change from $4.5M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Xenetic Biosciences- Warrants (19/07/2024)'s net tangible assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.